Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Endogenous TNFα mediates cell survival and chemotherapy resistance by activating the PI3K/Akt pathway in acute lymphoblastic leukemia cells

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

References

  1. Kobayashi D, Watanabe N, Yamauchi N, Tsuji N, Sato T, Niitsu Y . Endogenous tumor necrosis factor as a predictor of doxorubicin sensitivity in leukemic patients. Blood 1997; 89: 2472–2479.

    CAS  PubMed  Google Scholar 

  2. Zhou M, Findley HW, Ma L, Zaki S, Hill T, Hamid M, Hooper C, Ragab A . Effect of tumor necrosis factor-a on the proliferation of leukemic cells from children with B-cell precursor-acute lymphoblastic leukemia (BCP-ALL): studies of primary leukemic cells and BCP-ALL cell lines. Blood 1991; 77: 2002–2007.

    CAS  PubMed  Google Scholar 

  3. Zhou M, Yeager AM, Smith SD, Findley HW . Overexpression of the MDM2 gene by childhood acute lymphoblastic leukemia cells expressing the wild-type p53 gene. Blood 1995; 85: 1608–1614.

    CAS  PubMed  Google Scholar 

  4. Findley WH, Gu L, Yeager AM, Zhou M . Expression and regulation of Bcl-2, Bcl-xl and Bax correlate with p53 status and sensitivity to apoptosis in childhood acute lymphoblastic leukemia. Blood 1997; 89: 2986–2993.

    CAS  PubMed  Google Scholar 

  5. Sugarman B, Aggarwal B, Hass T, Figari I, Paladino M . Recombinant human tumor necrosis factor: effects on proliferation of normal and transformed cells. Science 1985; 230: 943–945.

    Article  CAS  Google Scholar 

  6. Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino Jr MA, Goeddel DV . The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci USA 1991; 88: 9292–9296.

    Article  CAS  Google Scholar 

  7. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner D . NF-kB activation by tumor necrosis factor requires the Akt serine-threonine kinase. Nature 1999; 40: 82–85.

    Article  Google Scholar 

  8. Fontaine V, Mohand-Said S, Hanoteau N, Fuchs C, Pfizenmaier K, Eisel U . Neurodegeneration and neuroprotection effects of tumor necrosis factor (TNF) in retinal ischema: opposite roles of TNF receptor 1 and TNF receptor 2. J Neurosci 2002; 22: RC216.

    Article  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from the NCI-NIH (R01 CA82323), The Leukemia and Lymphoma Society (6249-05) and CURE Childhood Cancer Inc.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gu, L., Findley, H., Zhu, N. et al. Endogenous TNFα mediates cell survival and chemotherapy resistance by activating the PI3K/Akt pathway in acute lymphoblastic leukemia cells. Leukemia 20, 900–904 (2006). https://doi.org/10.1038/sj.leu.2404160

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404160

This article is cited by

Search

Quick links